Abstract:Curcumin is the main component of the Chinese herbal plant turmeric, which has been demonstrated to possess antitumor and other pharmacological properties. The aim of the present study was to investigate the effects of curcumin on the viability, migration and apoptosis of human colorectal carcinoma HCT-116 cells, and to explore the underlying molecular mechanisms. In addition, it was investigated whether the antitumor effect of curcumin on HCT-116 cells could match that of the chemotherapeutic drug 5-fluorouracil (5-FU). HCT-116 cells were treated with curcumin (10, 20 and 30 mu M) and 5-FU (500 mu M), and cell viability and proliferation were detected by Cell Counting Kit-8 and colony formation assays, respectively. The migration and invasion of treated cells were determined using Transwell and carboxyfluorescein succinimidyl amino ester fluorescent labeling assays. Cell cycle distribution and apoptosis rates were detected by flow cytometry. Furthermore, cell morphology changes associated with apoptosis were observed by fluorescence microscopy with acridine orange/ethidium bromide dual staining. To investigate the possible underlying molecular mechanisms, the gene and protein levels of Fas, Fas-associated via death domain (FADD), caspase-8, caspase-3, matrix metalloproteinase (MMP)-9, nuclear factor (NF)-kappa B, E-cadherin and claudin-3 were detected using quantitative PCR analysis, zymography and western blotting. The results revealed that curcumin markedly inhibited the viability and proliferation of HCT-116 cells in a dose- and time-dependent manner. The migration, aggregation and invasion of HCT-116 cells into the lungs of mice were decreased by curcumin treatment in a dose-dependent manner. S-phase arrest and gradually increased apoptotic rates of HCT-116 cells were observed with increasing curcumin concentrations. Additionally, the mRNA and protein levels of apoptosis-associated proteins (Fas, FADD, caspase-8 and caspase-3) and E-cadherin in HCT-116 cells were upregulated following treatment with curcumin in a dose-dependent manner. By contrast, the expression of migration-associated proteins, including MMP-9, NF-kappa B and claudin-3, was downregulated with increasing curcumin concentrations. These data suggested that the inhibitory effect of curcumin on HCT-116 cells may match that of 5-FU. Therefore, curcumin induced cell apoptosis and inhibited tumor cell metastasis by regulating the NF-kappa B signaling pathway, and its therapeutic effect may be comparable to that of 5-FU.

Curcumin Enhances the Sensitivity of Lung Cancer Cells to Anti-tumor Agents

Expression Analysis Of Cdc42 In Lung Cancer And Modulation Of Its Expression By Curcumin In Lung Cancer Cell Lines

Potential Anti-Cancer Effect of Curcumin in Human Lung Squamous Cell Carcinoma

Anti-cancer Effects of Curcumin on Lung Cancer Through the Inhibition of EZH2 and NOTCH1.

Antitumor Activity of Curcumin by Modulation of Apoptosis and Autophagy in Human Lung Cancer A549 Cells Through Inhibiting PI3K/Akt/mTOR Pathway.

Curcumin Alters Gene Expression-Associated DNA Damage, Cell Cycle, Cell Survival and Cell Migration and Invasion in NCI-H460 Human Lung Cancer Cells in Vitro

Anticancer effects of curcumin on nude mice bearing lung cancer A549 cell subsets SP and NSP cells

Identification of Curcumin-Inhibited Extracellular Matrix Receptors in Non–small Cell Lung Cancer A549 Cells by RNA Sequencing

Chemical Markers' Knockout Coupled with UHPLC-HRMS-based Metabolomics Reveals Anti-Cancer Integration Effects of the Curcuminoids of Turmeric (curcuma Longa L.) on Lung Cancer Cell Line.

Curcumin enhances cisplatin sensitivity of human NSCLC cell lines through influencing Cu-Sp1-CTR1 regulatory loop

Curcumin inhibits human lung large cell carcinoma cancer tumour growth in a murine xenograft model.

Curcumol Inhibits Lung Adenocarcinoma Growth and Metastasis Via Inactivation of PI3K/AKT and Wnt/-Catenin Pathway

Curcumin increases exosomal TCF21 thus suppressing exosome-induced lung cancer.

The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis

Curcumin Sensitizes Lymphoma Cells to DNA Damage Agents Through Regulating Rad51-dependent Homologous Recombination.

Effect of Curcumin on Lapatinib Sensitivity and Lapatinib Resistance Associated Emt and Stem-Like Phenotype in Her2 Positive Breast Cancer.

Effect of curcumin on proliferation of human lung adenocarcinoma cell line A549/DDP

Curcumin-Induced Global Profiling of Transcriptomes in Small Cell Lung Cancer Cells

Superior Anticancer Efficacy of Curcumin-Loaded Nanoparticles Against Lung Cancer.

Curcumin induced autophagy anticancer effects on human lung adenocarcinoma cell line A549.

Antitumor Effects of Curcumin on the Proliferation, Migration and Apoptosis of Human Colorectal Carcinoma HCT‑116 Cells.